@Husultan
 Missouri, USA
Joined February 2011
  • Tweets87
  • Following194
  • Followers108
2Media
Hussein Sultan retweeted
Nan Zhang@NanZhangWistar2 Oct 2024
With the acceptance of our lab's first paper and the receipt of new funding, I'm excited to share that we are hiring at least a new postdoc. Please RT. #postdoc #ovariancancer #myeloidcells #innateimmunity nature.com/naturecareers/job…

Lab-Zhang - Post-Doctoral Fellow - Philadelphia, Pennsylvania (US)

The Wistar Institute has an opening for an ambitious and productive Post-Doctoral Fellow to join the laboratory of Dr. Nan Zhang.

nature.com
14
43
4
165
22,563
Hussein Sultan retweeted
Bernard A Fox@BernardAFox27 Sep 2024
Nobel Lareate @JimAllisonPhD @MDAndersonNews talks about #CTLA4 and #ICOS /lots of background sprinkled with keen insights! Also some great unpublished data.- not posted here @PamSharmaMDPhD ncifrederick.cancer.gov/even…
4
17
1,365
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer. New study from Apostolia Tsimberidou, Farah Alayli, Kwame Okrah, Padmanee Sharma @PamSharmaMDPhD and colleagues @MDAndersonNews @parkerici: hubs.la/Q02MKXkK0
4
6
1,760
Hussein Sultan retweeted
ACIR
@ACIR_org7 Aug 2024
CD4+ Tr1 cells marked by LILRB4 suppress antitumor immunity – no Foxp3 needed. @WUSTLmed @husultan bit.ly/4clxgtE
1
7
687
I am pleased to share with you that my paper has been accepted in Nature rdcu.be/dOPyr This work would not have been possible without the guidance of an exceptional mentor, support of awesome lab members and collaborators. @washupathedu @NateraGenetics @parkerici
9
3
45
3,096
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance | Nature Reviews Cancer nature.com/articles/s41568-0…

Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance

Nature Reviews Cancer - Adoptive cell therapies have emerged as promising approaches for the treatment of patients with cancer. Engineering cell therapies to confer resistance to small-molecule...

nature.com
8
32
2,687
Take note of 1-day @NIHAging workshop on Heterogeneity of Aging this Fri, Jun 21 (9am ET, can be viewed on zoom). Many cool scientists including @AdamsBioAging @george_kuchel , Luigi Ferrucci, yours truly and many others! Program and registration link: twtr.to/p6wIF
4
2
21
4,576
Happy to share our new study showing IL-22BP deficiency enhances gut microbiota's defense against infections. This boosts acetate production by Il22ra2–/–associated microbiota, suggesting IL-22BP as a therapeutic target. Led by @zefachi and @blandy pnas.org/doi/10.1073/pnas.23…
7
50
3,657
Congratulations to Dr. Robert Schreiber, the Andrew M. and Jane M. Bursky Distinguished Professor @wusm_pathology, who has been named the 2024 Senior Scientist Winner of the Innovators in Science Award in Cancer Immunology. Read more here: medicine.wustl.edu/news/schr… #wusmpathimm
2
6
43
2,914
Looking to do a postdoc in cancer immunology? Join the Burger Lab @OHSUKnight! We use genetically engineered 🐭 and cutting-edge single-cell analyses to investigate factors regulating T cell responses to cancer and design next generation immunotherapies. bit.ly/413vokF – at Portland, OR
4
30
3
64
15,080
The James P Allison institute inaugural symposium couldn’t have had a better start! @JimAllisonPhD @PamSharmaMDPhD @MDAndersonNews #CancerResearch #endcancer
3
1
21
2,576
It was a true honor to be recognized as the Presidential Travel Award recipient for SITC 2023.@WUSTL @sitcancer @wusm_pathology @WUSTLImmPostdoc
3
2
23
1,840
Amazing moments: It is truly remarkable when a great mentor recognizes his great mentors. @sitcancer @SitemanCenter
2
1
13
1,944
If you are interested in immune aging and/or immunometabolism - we are looking to expand our team (postdocs or visiting scientists) ideally with some cytometry background. Candidates from outside US are very welcome too!! please email martyomov (at) wustl.edu
49
2
130
19,705
Fundraiser by Cassie Godfrey : Let’s beat cancer’s butt for Eri’s sister! gofund.me/b5c81262
2
100
Congratulations to Dr. Neil Anderson, Dr. Carey-Ann Burnham, Dr. Bijal Parikh and Dr. Ali Ellebedy on receiving Dean's Impact Awards from @WUSTLmed. Read the full story here: pathology.wustl.edu/dr-neil-… #wusmpathimm #PathTwitter
1
6
2
41
6,874
Excited to share STAPLER, a language model to predict TCR – pMHC reactivity that outperforms prior models. And for ML aficionados: Description of a new data leakage problem inherent to a common negative data generation strategy. biorxiv.org/content/10.1101/… 🧵👇

STAPLER: Efficient learning of TCR-peptide specificity prediction from full-length TCR-peptide data

The prediction of peptide-MHC (pMHC) recognition by αβ T-cell receptors (TCRs) remains a major biomedical challenge. Here, we develop STAPLER (Shared TCR And Peptide Language bidirectional Encoder...

biorxiv.org
2
34
6
108
27,129
And thanks to @MStremska for moderating and facilitating a great discussion.
1
5
239
Hussein Sultan retweeted
AlspachLab@AlspachLab6 Feb 2023
The Alspach lab is hiring! We have openings for a research assistants, staff scientists and postdocs @slusom. Come figure out how sex impact anti-tumor immune responses with us! #postdoc #sciencejob slu.wd5.myworkdayjobs.com/Ca… slu.wd5.myworkdayjobs.com/Ca… slu.wd5.myworkdayjobs.com/Ca…
6
10
1,055
Excellent start for 2023, yet alarming findings especially about CRAB trends in Egypt. Thanks to @WafaaElWakeel, Soha Samir, Ali Elhalawany, @mostafa19772002 and big Thanks to @BritishCouncil for funding mdpi.com/2044200 #mdpiantibiotics via @antibioticsmdpi

Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends...

Acinetobacter baumannii is a problematic pathogen of global concern. It causes multiple types of infection, especially among immunocompromised individuals in intensive care units. One of the most...

mdpi.com
1
1
1
7
1,151
Load more